Login
Sign Up
Search markets and profiles
Activity
Get Started
When will the FDA approve Intellia Therapeutics' lonvo-z? — Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema
$0 volume
Before 2028
69.0%
$0.69
Before October 2027
52.0%
$0.52
Before July 2027
27.0%
$0.27
1h
6h
24h
7d
1M
all
Loading chart...
Kalshi
Best value
$457 Vol
$0.69
Selected Bet
Before 2028
Trading via
Kalshi
Market Volume
$457
Yes
69.0%
No
31.0%
Rules
Trade
Comments
Whales
Positions
Activity
Volume
No whale trades found for this event.